ibrutinib,venetoclax,Obinutuzumab,rituximab
roche,janssen,abbvie
['cll13', 'cll', 'venetoclax', ' ave ', 'gaia', '#12 ']
congress | #ash22 eugen tausch shared results from the phase iii gaia/cll13 trial, comparing 3 time-limited venetoclax combos in cll. ras/raf mutations were prognostic with venetoclax therapy. braf/nras/kras mutations were associated with shorter pfs in venetoclax treated pts. 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm